Skip to main content
Top
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 7/2005

01-07-2005 | Clinical Investigation

Platelet aggregates in various stages of diabetic retinopathy: evaluation using the particle-counting light-scattering method

Authors: Takami Yamamoto, Motohiro Kamei, Norihiko Yokoi, Toru Yasuhara, Mamoru Tei, Shigeru Kinoshita

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 7/2005

Login to get access

Abstract

Aims

To investigate the possible correlation between platelet aggregation and the severity of diabetic retinopathy using the light-scattering method.

Methods

Using a light-scattering platelet aggregometer, we measured spontaneous platelet aggregation in 86 diabetics with retinopathy of varying severity and 30 healthy volunteers (controls). Platelet aggregates were classified as small, medium, and large according to their light intensity; patients were grouped based on the severity of retinopathy. In each patient group, we recorded for 10 min the total light intensities emitted by each aggregate size in the area under the curve (AUC). Then, we compared the AUC of each level of retinopathy severity with the controls and determined the correlation between the AUC of each aggregate size and each severity level.

Results

Of the 86 diabetics, 22 had no apparent retinopathy (NAR), 13 had mild nonproliferative diabetic retinopathy (NPDR), 17 had moderate NPDR, 12 had severe NPDR, and 22 had proliferative diabetic retinopathy (PDR). While the NAR group manifested significantly more small aggregates than the controls (20.5×106 versus 8.3×106 a.u., p=0.024), none of the other groups showed a significant increase in aggregates of any size. In the AUC of large aggregates, there was a weak-positive correlation with the severity of retinopathy (r=0.255, p=0.018); in the AUC of small and medium aggregates, there was no correlation.

Conclusion

Although we did not find a significant correlation between platelet aggregation and the severity of diabetic retinopathy, our pilot study did detect some tendencies. Further studies on larger populations are underway to determine whether these tendencies are real.
Literature
1.
go back to reference Agardh CD, Agardh E, Bauer B (1987) Platelet aggregation in type I diabetics with and without proliferative retinopathy. Acta Ophthalmol 65:358–362 Agardh CD, Agardh E, Bauer B (1987) Platelet aggregation in type I diabetics with and without proliferative retinopathy. Acta Ophthalmol 65:358–362
2.
go back to reference Born GVR (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194:927–929 Born GVR (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194:927–929
3.
go back to reference Born GVR (1970) Observations on the change in shape of blood platelets brought about by adenosine diphosphate. J Physiol 209:487–511 Born GVR (1970) Observations on the change in shape of blood platelets brought about by adenosine diphosphate. J Physiol 209:487–511
4.
go back to reference ETDRS Investigators (1992) Aspirin effects on mortality and morbidity in patients with diabetes mellitus. JAMA 268:1292–1300 ETDRS Investigators (1992) Aspirin effects on mortality and morbidity in patients with diabetes mellitus. JAMA 268:1292–1300
5.
go back to reference Fukuda K, Ozaki Y, Satoh K, Kume S, Tawata M, Onaya T, Sakurada K, Seto M, Sasaki Y (1997) Phosphorylation of myosin light chain in resting platelets from NIDDM patients is enhanced: correlation with spontaneous aggregation. Diabetes 46:488–493 Fukuda K, Ozaki Y, Satoh K, Kume S, Tawata M, Onaya T, Sakurada K, Seto M, Sasaki Y (1997) Phosphorylation of myosin light chain in resting platelets from NIDDM patients is enhanced: correlation with spontaneous aggregation. Diabetes 46:488–493
6.
go back to reference Fusegawa Y, Goto S, Handa S, Kawada T, Ando Y (1999) Platelet spontaneous aggregation in platelet-rich plasma is increased in habitual smokers. Thromb Res 93:271–278CrossRef Fusegawa Y, Goto S, Handa S, Kawada T, Ando Y (1999) Platelet spontaneous aggregation in platelet-rich plasma is increased in habitual smokers. Thromb Res 93:271–278CrossRef
7.
go back to reference Gear AR, Lambrecht JK (1981) Reduction in single platelets during primary and secondary aggregation. Thromb Haemost 45:298 (letter) Gear AR, Lambrecht JK (1981) Reduction in single platelets during primary and secondary aggregation. Thromb Haemost 45:298 (letter)
8.
go back to reference Gensini GF, Abbate R, Favilla S, Neri Serneri GG (1979) Changes of platelet function and blood clotting in diabetes mellitus. Thromb Haemost 42:983–993 Gensini GF, Abbate R, Favilla S, Neri Serneri GG (1979) Changes of platelet function and blood clotting in diabetes mellitus. Thromb Haemost 42:983–993
9.
go back to reference Halushka PV, Rogers RC, Loadholdt CB, Colwell JA (1981) Increased platelet thromboxane synthesis in diabetes mellitus. J Lab Clin Med 97:87–96 Halushka PV, Rogers RC, Loadholdt CB, Colwell JA (1981) Increased platelet thromboxane synthesis in diabetes mellitus. J Lab Clin Med 97:87–96
10.
go back to reference Haque SF, Matsubayashi H, Izumi S, Sugi T, Arai T, Kondo A, Makino T (2001) Sex difference in platelet aggregation detected by new aggregometry using light scattering. Endocr J 48:33–41 Haque SF, Matsubayashi H, Izumi S, Sugi T, Arai T, Kondo A, Makino T (2001) Sex difference in platelet aggregation detected by new aggregometry using light scattering. Endocr J 48:33–41
11.
go back to reference Ishii H, Umeda F, Nawata H (1992) Platelet function in diabetes mellitus. Diabetes/Metab Rev 8:53–66 Ishii H, Umeda F, Nawata H (1992) Platelet function in diabetes mellitus. Diabetes/Metab Rev 8:53–66
12.
go back to reference Iwase E, Tawata M, Aida K, Ozaki Y, Kume S, Satoh K, Qi R, Onaya T (1998) A cross-sectional evaluation of spontaneous platelet aggregation in relation to complications in patients with type II diabetes mellitus. Metabolism 47:699–705CrossRef Iwase E, Tawata M, Aida K, Ozaki Y, Kume S, Satoh K, Qi R, Onaya T (1998) A cross-sectional evaluation of spontaneous platelet aggregation in relation to complications in patients with type II diabetes mellitus. Metabolism 47:699–705CrossRef
13.
go back to reference Kitek A, Breddin K (1980) Optical density variations and microscopic observations in the evaluation of platelet shape change and microaggregate formation. Thromb Haemost 44:154–158 Kitek A, Breddin K (1980) Optical density variations and microscopic observations in the evaluation of platelet shape change and microaggregate formation. Thromb Haemost 44:154–158
14.
go back to reference Matsuno H, Kozawa O, Nagashima S, Kanamaru M, Uematsu T (1999) Comparative antiplatelet effects of aspirin, vapiprost and GR144053, a GPIIb/IIIa antagonist, with a special reference to the role of platelet microaggregates. Br J Pharmacol 127:1129–1134 Matsuno H, Kozawa O, Nagashima S, Kanamaru M, Uematsu T (1999) Comparative antiplatelet effects of aspirin, vapiprost and GR144053, a GPIIb/IIIa antagonist, with a special reference to the role of platelet microaggregates. Br J Pharmacol 127:1129–1134
15.
go back to reference Miyamoto S, Kawano H, Sakamoto T, Soejima H, Kajiwara I, Shimomura H, Kojima S, Hokamaki J, Sugiyama S, Hirai N, Yoshimura M, Ozaki Y, Ogawa H (2003) Formation of platelet microaggregates correlates with adverse clinical outcome in patients with coronary artery disease. Thromb Haemost 89:681–686 Miyamoto S, Kawano H, Sakamoto T, Soejima H, Kajiwara I, Shimomura H, Kojima S, Hokamaki J, Sugiyama S, Hirai N, Yoshimura M, Ozaki Y, Ogawa H (2003) Formation of platelet microaggregates correlates with adverse clinical outcome in patients with coronary artery disease. Thromb Haemost 89:681–686
16.
go back to reference Nakamura T, Ariyoshi H, Kambayashi J, Ikeda M, Kawasaki T, Sakon M, Monden M (1997) Effect of low concentration of epinephrine on human platelet aggregation analyzed by particle counting method and confocal microscopy. J Lab Clin Med 130:262–270CrossRef Nakamura T, Ariyoshi H, Kambayashi J, Ikeda M, Kawasaki T, Sakon M, Monden M (1997) Effect of low concentration of epinephrine on human platelet aggregation analyzed by particle counting method and confocal microscopy. J Lab Clin Med 130:262–270CrossRef
17.
go back to reference Ozaki Y, Satoh K, Yatomi Y, Yamamoto T, Shirasawa Y, Kume S (1994) Detection of platelet aggregates with a particle counting method using light scattering. Anal Biochem 218:284–294CrossRef Ozaki Y, Satoh K, Yatomi Y, Yamamoto T, Shirasawa Y, Kume S (1994) Detection of platelet aggregates with a particle counting method using light scattering. Anal Biochem 218:284–294CrossRef
18.
go back to reference Sagel J, ColwellJA, Crook L, Laimins M (1975) Increased platelet aggregation in early diabetes mellitus. Ann Intern Med 82:733–738PubMed Sagel J, ColwellJA, Crook L, Laimins M (1975) Increased platelet aggregation in early diabetes mellitus. Ann Intern Med 82:733–738PubMed
19.
go back to reference Sakamoto T, Ogawa H, Kawano H, Hirai N, Miyamoto S, Takazoe K, Soejima H, Kugiyama K, Yoshimura M, Yasue H (2000) Rapid change of platelet aggregability in acute hyperglycemia. Thromb Haemost 83:475–479 Sakamoto T, Ogawa H, Kawano H, Hirai N, Miyamoto S, Takazoe K, Soejima H, Kugiyama K, Yoshimura M, Yasue H (2000) Rapid change of platelet aggregability in acute hyperglycemia. Thromb Haemost 83:475–479
20.
go back to reference Spencer BK III, Ehtisham M (1999) Will blocking the platelet save the diabetic? Circulation 100:2466–2468 Spencer BK III, Ehtisham M (1999) Will blocking the platelet save the diabetic? Circulation 100:2466–2468
21.
go back to reference The DAMAD Study Group (1989) Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy: a multicenter randomized controlled clinical trial. Diabetes 38:491–498 The DAMAD Study Group (1989) Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy: a multicenter randomized controlled clinical trial. Diabetes 38:491–498
22.
go back to reference The TIMAD Study Group (1990) Ticlopidine treatment reduces the progression of non-proliferative diabetic retinopathy. Arch Ophthalmol 108:1577–1583 The TIMAD Study Group (1990) Ticlopidine treatment reduces the progression of non-proliferative diabetic retinopathy. Arch Ophthalmol 108:1577–1583
23.
go back to reference Tohgi H, Takahashi H, Watanabe K, Kuki H, Shirasawa Y (1996) Development of large platelet aggregates from small aggregates as determined by laser-light scattering: effects of aggregant concentration and antiplatelet medication. Thromb Haemost 75:838–843 Tohgi H, Takahashi H, Watanabe K, Kuki H, Shirasawa Y (1996) Development of large platelet aggregates from small aggregates as determined by laser-light scattering: effects of aggregant concentration and antiplatelet medication. Thromb Haemost 75:838–843
24.
go back to reference Tomida Y, Iino S, Nishikawa M, Hidaka H (1998) A new system to detect native microaggregates of platelets in vivo, with a novel platelet aggregometer employing laser light scattering. Thromb Res 92:221–228CrossRef Tomida Y, Iino S, Nishikawa M, Hidaka H (1998) A new system to detect native microaggregates of platelets in vivo, with a novel platelet aggregometer employing laser light scattering. Thromb Res 92:221–228CrossRef
25.
go back to reference Vinik AI, Erbas T, Park TS, Nolan R, Pittenger GL (2001) Platelet dysfunction in type 2 diabetes. Diabetes Care 24:1476–1485 Vinik AI, Erbas T, Park TS, Nolan R, Pittenger GL (2001) Platelet dysfunction in type 2 diabetes. Diabetes Care 24:1476–1485
26.
go back to reference Wilkinson CP, Ferris FL III, Klein RE, Lee PP, Agardh CD, Davis M, Dills D, Kampik A, Pararajasegaram R, Verdaguer JT, Global Diabetic Retinopathy Project Group (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110:1677–1682CrossRef Wilkinson CP, Ferris FL III, Klein RE, Lee PP, Agardh CD, Davis M, Dills D, Kampik A, Pararajasegaram R, Verdaguer JT, Global Diabetic Retinopathy Project Group (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110:1677–1682CrossRef
27.
go back to reference Yamamoto T, Egawa Y, Shirasawa T (1995) A laser light scattering in situ system for counting aggregates in blood platelet aggregation. Meas Sci Technol 6:174–180CrossRef Yamamoto T, Egawa Y, Shirasawa T (1995) A laser light scattering in situ system for counting aggregates in blood platelet aggregation. Meas Sci Technol 6:174–180CrossRef
28.
go back to reference Yamamoto T, Kamei M, Yokoi N, Yasuhara T, Tei M, Kinoshita S (2004) Comparative effect of antiplatelet therapy in retinal vein occlusion evaluated by the particle-counting method using light scattering. Am J Ophthalmol 138:809–817 Yamamoto T, Kamei M, Yokoi N, Yasuhara T, Tei M, Kinoshita S (2004) Comparative effect of antiplatelet therapy in retinal vein occlusion evaluated by the particle-counting method using light scattering. Am J Ophthalmol 138:809–817
Metadata
Title
Platelet aggregates in various stages of diabetic retinopathy: evaluation using the particle-counting light-scattering method
Authors
Takami Yamamoto
Motohiro Kamei
Norihiko Yokoi
Toru Yasuhara
Mamoru Tei
Shigeru Kinoshita
Publication date
01-07-2005
Publisher
Springer-Verlag
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 7/2005
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-004-1101-x

Other articles of this Issue 7/2005

Graefe's Archive for Clinical and Experimental Ophthalmology 7/2005 Go to the issue

Announcements

July 2005